title: Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis.
authors.forename: M J
authors.initials: MJ
authors.lastname: Gill
authors.forename: N J
authors.initials: NJ
authors.lastname: Ostrop
authors.forename: W D
authors.initials: WD
authors.lastname: Fiske
authors.forename: J M
authors.initials: JM
authors.lastname: Brennan
mesh_terms: D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D048588:Benzoxazines; D003521:Cyclopropanes; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010078:Oxazines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010531:Peritoneal Dialysis, Continuous Ambulatory; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz